McMillan Matthew T, Malleo Giuseppe, Bassi Claudio, Sprys Michael H, Ecker Brett L, Drebin Jeffrey A, Vollmer Charles M
Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Department of Surgery, University of Verona, Verona, Italy.
HPB (Oxford). 2017 Jun;19(6):515-524. doi: 10.1016/j.hpb.2017.01.022. Epub 2017 Feb 12.
Clinically relevant postoperative pancreatic fistula (CR-POPF) is a morbid complication following pancreatoduodenectomy (PD). It is unclear how pancreatic surgeons perceive risk for this complication, and the implications thereof.
A web-based survey was distributed to members of 22 international GI surgical societies. CR-POPF risk factors were categorized as follows: (i) patient factors, (ii) pancreatic gland characteristics, (iii) intraoperative variables, (iv) perioperative mitigation techniques, or (v) institutional features.
Surveys were completed by 897 surgeons worldwide. The most commonly cited contributors to CR-POPF risk were gland characteristics (90.7%), while patient and intraoperative factors were selected 71.2 and 69.3% of the time, respectively. Conversely, institutional features (31.7%) and perioperative mitigation techniques (21.3%) were rarely recognized. Eighty percent of surgeons use drain amylase concentration to guide drain removal decision-making; however, only 45.2% of surgeon remove drains early based upon drain amylase values. When evaluating clinical scenarios, surgeons were able to identify both negligible and high risk scenarios but struggled to differentiate between low and moderate CR-POPF risk.
This international study analyzed how surgeons discern CR-POPF risk for PD. There was considerable variability in surgeons' perceptions of risk, which may have an adverse effect on the clinical use of risk adjustment measures.
临床相关的术后胰瘘(CR-POPF)是胰十二指肠切除术(PD)后的一种严重并发症。目前尚不清楚胰腺外科医生如何看待这种并发症的风险及其影响。
向22个国际胃肠外科协会的成员开展了一项基于网络的调查。CR-POPF的风险因素分类如下:(i)患者因素,(ii)胰腺特征,(iii)术中变量,(iv)围手术期缓解技术,或(v)机构特征。
全球897名外科医生完成了调查。CR-POPF风险最常被提及的因素是胰腺特征(90.7%),而患者和术中因素分别在71.2%和69.3%的情况下被选中。相反,机构特征(31.7%)和围手术期缓解技术(21.3%)很少被提及。80%的外科医生使用引流液淀粉酶浓度来指导拔管决策;然而,只有45.2%的外科医生根据引流液淀粉酶值提前拔管。在评估临床情况时,外科医生能够识别可忽略不计和高风险的情况,但难以区分低和中度CR-POPF风险。
这项国际研究分析了外科医生如何识别PD的CR-POPF风险。外科医生对风险的认知存在很大差异,这可能会对风险调整措施的临床应用产生不利影响。